|

IDMet (RaDiCo Cohort) (RaDiCo-IDMet)

RECRUITINGSponsored by Institut National de la Santé Et de la Recherche Médicale, France
Actively Recruiting
SponsorInstitut National de la Santé Et de la Recherche Médicale, France
Started2017-03-10
Est. completion2028-03
Eligibility
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT05945576

Summary

The goal of this observational study is to describe the natural history of imprinting disorders (IDs) according to their metabolic profile in all patients (adults and children) affected with an ID regardless of the severity of the disease, with a molecular characterization, with a signed informed consent for all subjects, followed in one partner's center. The main questions it aims to answer are: * Can we identify common metabolic profiles for all imprinted diseases? * Which imprinting disorders have an impact on the metabolic profiles of IDs? * Which are the metabolic risks associated to IDs? * Can we use the metabolic profiles for the clinical classification and prognosis of IDs? * Are there common therapeutic approaches for all IDs?

Eligibility

Healthy volunteers accepted
Inclusion Criteria:

* Patients (adults and children) affected with an ID regardless of the severity of the disease
* A confirmed diagnosis of ID (based on molecular diagnosis)
* A signed informed consent for adults or signed informed consent of parents/guardians of minors/ protected adult.

Non-Inclusion Criteria:

There are no non-inclusion criteria.

Conditions10

Angelman SyndromeBeckwith-Wiedemann SyndromeDiabetesFamilial Precocious PubertyKagami-Ogata SyndromePrader-Willi SyndromePseudohypoparathyroidismSilver Russell SyndromeTemple SyndromeTransient Neonatal Diabetes Mellitus

Browse More Trials

Diabetes trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.